Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention

Despite the recent progress in interferon (IFN) therapies for chronic hepatitis C, liver cirrhosis remains refractory. One of the major obstacles to successful IFN therapy is low platelet count. Currently, splenic interventions, such as partial splenic embolization (PSE) or surgical splenectomy, hav...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-hei, Matsuda, Yasunobu, Aoyagi, Yutaka
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2010
Teme:
Published: July 2010
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2929425/
https://ncbi.nlm.nih.gov/pubmed/20805953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000318742
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki